Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Protocolised odontological assessment of patients with primary Sjögren's syndrome.

Reumatologia clinica

Fernández Castro M, López-Pintor RM, Serrano J, Ramírez L, Sanz M, Andreu JL, Muñoz Fernández S.
PMID: 30745279
Reumatol Clin (Engl Ed). 2021 Jan;17(1):25-31. doi: 10.1016/j.reuma.2018.12.005. Epub 2019 Feb 10.

OBJECTIVE: The aim of this study is to describe the findings of a protocolised odontological evaluation of patients with primary Sjögren's syndrome (pSS) treated in rheumatology units in the Community of Madrid.METHODS: Multicentric descriptive study in which pSS patients...

Cite
Fernández Castro M, López-Pintor RM, Serrano J, et al. Evaluación protocolizada odontológica en el paciente con síndrome de Sjögren primario. Proyecto EPOX-SSp: metodología y objetivos. Protocolised odontological assessment of patients with primary Sjögren's syndrome. Reumatol Clin (Engl Ed). 2019;17(1):25-31doi: 10.1016/j.reuma.2018.12.005.
Fernández Castro, M., López-Pintor, R. M., Serrano, J., Ramírez, L., Sanz, M., Andreu, J. L., Muñoz Fernández, S. (2021). Evaluación protocolizada odontológica en el paciente con síndrome de Sjögren primario. Proyecto EPOX-SSp: metodología y objetivos. Protocolised odontological assessment of patients with primary Sjögren's syndrome. Reumatologia clinica, 17(1), 25-31. https://doi.org/10.1016/j.reuma.2018.12.005
Fernández Castro, Mónica, et al. "Evaluación protocolizada odontológica en el paciente con síndrome de Sjögren primario. Proyecto EPOX-SSp: metodología y objetivos." Protocolised odontological assessment of patients with primary Sjögren's syndrome. Reumatologia clinica vol. 17,1 (2021): 25-31. doi: https://doi.org/10.1016/j.reuma.2018.12.005
Fernández Castro M, López-Pintor RM, Serrano J, Ramírez L, Sanz M, Andreu JL, Muñoz Fernández S. Evaluación protocolizada odontológica en el paciente con síndrome de Sjögren primario. Proyecto EPOX-SSp: metodología y objetivos. Protocolised odontological assessment of patients with primary Sjögren's syndrome. Reumatol Clin (Engl Ed). 2021 Jan;17(1):25-31. doi: 10.1016/j.reuma.2018.12.005. Epub 2019 Feb 10. Spanish. PMID: 30745279.
Copy Download .nbib Format: NLM
Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Buigues-Pastor L, Sánchez-Chorro JL, Saurí-Ferrer MI, Muñoz-Fernández JI, Uso-Talamantes R, Ortiz-Rodríguez O.
PMID: 27201035
Value Health. 2014 Nov;17(7):A415. doi: 10.1016/j.jval.2014.08.1002. Epub 2014 Oct 26.

No abstract available.

Cite
Buigues-Pastor L, Sánchez-Chorro JL, Saurí-Ferrer MI, et al. Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment. Value Health. 2014;17(7):A415doi: 10.1016/j.jval.2014.08.1002.
Buigues-Pastor, L., Sánchez-Chorro, J. L., Saurí-Ferrer, M. I., Muñoz-Fernández, J. I., Uso-Talamantes, R., & Ortiz-Rodríguez, O. (2014). Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A415. https://doi.org/10.1016/j.jval.2014.08.1002
Buigues-Pastor, L, et al. "Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A415. doi: https://doi.org/10.1016/j.jval.2014.08.1002
Buigues-Pastor L, Sánchez-Chorro JL, Saurí-Ferrer MI, Muñoz-Fernández JI, Uso-Talamantes R, Ortiz-Rodríguez O. Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment. Value Health. 2014 Nov;17(7):A415. doi: 10.1016/j.jval.2014.08.1002. Epub 2014 Oct 26. PMID: 27201035.
Copy Download .nbib Format: NLM
[Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression].

Reumatologia clinica

García de Vicuña R, Padilla B, Carreño L, Muñoz Fernández S, Martín Mola E, Gómez-Reino J, Martínez Taboada V, López Sanromán A, Pérez Gisbert J, Díaz González F, Hinojosa Del Val J, Bouza E, Carmona L.
PMID: 21794681
Reumatol Clin. 2010 Jan-Feb;6(1):63-8. doi: 10.1016/j.reuma.2009.09.011. Epub 2009 Nov 27.

The Spanish Society of Rheumatology (SER), through a multidiscipline task force, has elaborated a document with specific recommendations for specialists in Rheumatology, emphasizing the special needs of patients with rheumatic diseases, with the objective of informing and orienting health...

Cite
García de Vicuña R, Padilla B, Carreño L, et al. Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión. [Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression]. Reumatol Clin. 2009;6(1):63-8doi: 10.1016/j.reuma.2009.09.011.
García de Vicuña, R., Padilla, B., Carreño, L., Muñoz Fernández, S., Martín Mola, E., Gómez-Reino, J., Martínez Taboada, V., López Sanromán, A., Pérez Gisbert, J., Díaz González, F., Hinojosa Del Val, J., Bouza, E., & Carmona, L. (2010). Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión. [Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression]. Reumatologia clinica, 6(1), 63-8. https://doi.org/10.1016/j.reuma.2009.09.011
García de Vicuña, Rosario, et al. "Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión." [Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression]. Reumatologia clinica vol. 6,1 (2010): 63-8. doi: https://doi.org/10.1016/j.reuma.2009.09.011
García de Vicuña R, Padilla B, Carreño L, Muñoz Fernández S, Martín Mola E, Gómez-Reino J, Martínez Taboada V, López Sanromán A, Pérez Gisbert J, Díaz González F, Hinojosa Del Val J, Bouza E, Carmona L. Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión. [Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression]. Reumatol Clin. 2010 Jan-Feb;6(1):63-8. doi: 10.1016/j.reuma.2009.09.011. Epub 2009 Nov 27. Spanish. PMID: 21794681.
Copy Download .nbib Format: NLM
Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?.

Cytotherapy

Rodríguez-Acosta A, Chaparro-García J, De-Toro I, Maldonado-Sánchez R, Muñoz-Fernández R, Antúnez C, Frecha C, Leyva L.
PMID: 35033424
Cytotherapy. 2022 Jan 12; doi: 10.1016/j.jcyt.2021.11.002. Epub 2022 Jan 12.

BACKGROUND: Automated growth-based methods for sterility testing of cell-therapy products should be qualified to demonstrate that they are equivalent to, or better than, the conventional reference method. The aim of the present study was to assess the ability of...

Cite
Rodríguez-Acosta A, Chaparro-García J, De-Toro I, et al. Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?. Cytotherapy. 2022;doi: 10.1016/j.jcyt.2021.11.002.
Rodríguez-Acosta, A., Chaparro-García, J., De-Toro, I., Maldonado-Sánchez, R., Muñoz-Fernández, R., Antúnez, C., Frecha, C., & Leyva, L. (2022). Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?. Cytotherapy, . https://doi.org/10.1016/j.jcyt.2021.11.002
Rodríguez-Acosta, Antonio, et al. "Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?." Cytotherapy vol. (2022). doi: https://doi.org/10.1016/j.jcyt.2021.11.002
Rodríguez-Acosta A, Chaparro-García J, De-Toro I, Maldonado-Sánchez R, Muñoz-Fernández R, Antúnez C, Frecha C, Leyva L. Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?. Cytotherapy. 2022 Jan 12; doi: 10.1016/j.jcyt.2021.11.002. Epub 2022 Jan 12. PMID: 35033424.
Copy Download .nbib Format: NLM
[Not Available].

Reumatologia clinica

Collantes E, Fernández Sueiro JL, García-Vicuña R, Gratacós J, Mulero J, Muñoz Fernández S, Sanmartí R, Zarco P, Angel Abad M, Batlle E, de Dios Cañete J, González Crespo MR, González C, Juanola X, Sanz J, Rivera J.
PMID: 21794471
Reumatol Clin. 2007 Jul;3:S60-70. doi: 10.1016/S1699-258X(07)73645-8. Epub 2008 Dec 29.

No abstract available.

Cite
Collantes E, Fernández Sueiro JL, García-Vicuña R, et al. Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica. [Not Available]. Reumatol Clin. 2008;3:S60-70doi: 10.1016/S1699-258X(07)73645-8.
Collantes, E., Fernández Sueiro, J. L., García-Vicuña, R., Gratacós, J., Mulero, J., Muñoz Fernández, S., Sanmartí, R., Zarco, P., Angel Abad, M., Batlle, E., de Dios Cañete, J., González Crespo, M. R., González, C., Juanola, X., Sanz, J., & Rivera, J. (2007). Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica. [Not Available]. Reumatologia clinica, 3S60-70. https://doi.org/10.1016/S1699-258X(07)73645-8
Collantes, Eduardo, et al. "Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica." [Not Available]. Reumatologia clinica vol. 3 (2007): S60-70. doi: https://doi.org/10.1016/S1699-258X(07)73645-8
Collantes E, Fernández Sueiro JL, García-Vicuña R, Gratacós J, Mulero J, Muñoz Fernández S, Sanmartí R, Zarco P, Angel Abad M, Batlle E, de Dios Cañete J, González Crespo MR, González C, Juanola X, Sanz J, Rivera J. Actualización del Consenso de la Sociedad Española de Reumatología sobre el uso de antagonistas del TNFα en las espondiloartritis, incluida la artritis psoriásica. [Not Available]. Reumatol Clin. 2007 Jul;3:S60-70. doi: 10.1016/S1699-258X(07)73645-8. Epub 2008 Dec 29. Spanish. PMID: 21794471.
Copy Download .nbib Format: NLM
[Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis].

Reumatologia clinica

Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, Martín Mola E, Marenco de la Fuente JL, González Álvaro I, Muñoz Fernández S, Gómez-Reino Carnota J, Carreño Pérez L, Batlle Gualda E, Balsa Criado A, Andreu JL, Alvaro-Gracia JM, Martínez López JA, Loza Santamaría E.
PMID: 21794674
Reumatol Clin. 2010 Jan-Feb;6(1):23-36. doi: 10.1016/j.reuma.2009.10.006. Epub 2009 Dec 06.

OBJECTIVE: To provide a reference to rheumatologists and to those involved in the treatment of RA who are using, or about to use biologic therapy.METHODS: Recommendations were developed following a nominal group methodology and based on systematic reviews. The...

Cite
Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, et al. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. [Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis]. Reumatol Clin. 2009;6(1):23-36doi: 10.1016/j.reuma.2009.10.006.
Tornero Molina, J., Sanmartí Sala, R., Rodríguez Valverde, V., Martín Mola, E., Marenco de la Fuente, J. L., González Álvaro, I., Muñoz Fernández, S., Gómez-Reino Carnota, J., Carreño Pérez, L., Batlle Gualda, E., Balsa Criado, A., Andreu, J. L., Alvaro-Gracia, J. M., Martínez López, J. A., & Loza Santamaría, E. (2010). Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. [Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis]. Reumatologia clinica, 6(1), 23-36. https://doi.org/10.1016/j.reuma.2009.10.006
Tornero Molina, Jesús, et al. "Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide." [Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis]. Reumatologia clinica vol. 6,1 (2010): 23-36. doi: https://doi.org/10.1016/j.reuma.2009.10.006
Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, Martín Mola E, Marenco de la Fuente JL, González Álvaro I, Muñoz Fernández S, Gómez-Reino Carnota J, Carreño Pérez L, Batlle Gualda E, Balsa Criado A, Andreu JL, Alvaro-Gracia JM, Martínez López JA, Loza Santamaría E. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. [Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis]. Reumatol Clin. 2010 Jan-Feb;6(1):23-36. doi: 10.1016/j.reuma.2009.10.006. Epub 2009 Dec 06. Spanish. PMID: 21794674.
Copy Download .nbib Format: NLM
Reliability of Sonography Measures of the Lumbar Multifidus and Transversus Abdominis during Static and Dynamic Activities in Subjects with Non-Specific Chronic Low Back Pain.

Diagnostics (Basel, Switzerland)

Sánchez Romero EA, Alonso Pérez JL, Muñoz Fernández AC, Battaglino A, Castaldo M, Cleland JA, Villafañe JH.
PMID: 33915766
Diagnostics (Basel). 2021 Apr 01;11(4). doi: 10.3390/diagnostics11040632.

PURPOSE: The purpose of this study was to investigate the test-retest reliability of ultrasound (US) thickness measurements and the muscle contraction ratio (CR) of lumbar multifidus (LM) and transversus abdominis (TA) muscles in participants with and without nonspecific chronic...

Cite
Sánchez Romero EA, Alonso Pérez JL, Muñoz Fernández AC, et al. Reliability of Sonography Measures of the Lumbar Multifidus and Transversus Abdominis during Static and Dynamic Activities in Subjects with Non-Specific Chronic Low Back Pain. Diagnostics (Basel). 2021;11(4)doi: 10.3390/diagnostics11040632.
Sánchez Romero, E. A., Alonso Pérez, J. L., Muñoz Fernández, A. C., Battaglino, A., Castaldo, M., Cleland, J. A., & Villafañe, J. H. (2021). Reliability of Sonography Measures of the Lumbar Multifidus and Transversus Abdominis during Static and Dynamic Activities in Subjects with Non-Specific Chronic Low Back Pain. Diagnostics (Basel, Switzerland), 11(4), . https://doi.org/10.3390/diagnostics11040632
Sánchez Romero, Eleuterio A, et al. "Reliability of Sonography Measures of the Lumbar Multifidus and Transversus Abdominis during Static and Dynamic Activities in Subjects with Non-Specific Chronic Low Back Pain." Diagnostics (Basel, Switzerland) vol. 11,4 (2021). doi: https://doi.org/10.3390/diagnostics11040632
Sánchez Romero EA, Alonso Pérez JL, Muñoz Fernández AC, Battaglino A, Castaldo M, Cleland JA, Villafañe JH. Reliability of Sonography Measures of the Lumbar Multifidus and Transversus Abdominis during Static and Dynamic Activities in Subjects with Non-Specific Chronic Low Back Pain. Diagnostics (Basel). 2021 Apr 01;11(4). doi: 10.3390/diagnostics11040632. PMID: 33915766; PMCID: PMC8065451.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries